Announcement on Receiving the Decision on Administrative Supervision Measures from the Xinjiang Securities Regulatory Bureau

Chenguang Biotech Group Co., Ltd.·August 14, 2026·2 pages

✨ AI Summary

The company received a decision from the Xinjiang Securities Regulatory Bureau regarding a violation of non-operational fund occupation. The company borrowed RMB 136 million from its subsidiary's subsidiaries and repaid it with interest. The bureau ordered corrective action and issued a warning, to be recorded in the market integrity file. The company stated this will not affect operations.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 300138

Securities Abbreviation: Chenguang Biology

Announcement No.: 2026-086

Chenguang Biology Science and Technology Group Co., Ltd.

Announcement on Receiving the Decision on Administrative Supervision Measures from the Xinjiang Securities Regulatory Bureau

The Company and all members of the Board of Directors guarantee that the information disclosed in this announcement is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.

Chenguang Biology Science and Technology Group Co., Ltd. (hereinafter referred to as the "Company" or "Chenguang Biology") recently received a Decision on Administrative Supervision Measures from the Xinjiang Regulatory Bureau of the China Securities Regulatory Commission (hereinafter referred to as the "Xinjiang Securities Regulatory Bureau"), titled "Decision on Ordering Correction and Issuing a Warning Letter to Chenguang Biology Science and Technology Group Co., Ltd." (No. [2026] 40) (hereinafter referred to as the "Decision"). The relevant matters are hereby announced as follows:

I. Content of the "Decision"

Chenguang Biology Science and Technology Group Co., Ltd.:

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.